Evidence map›Paper›PMID 39748308›Full record

ArticleBMC medical imaging2025

Preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma: an integrative approach combining ultrasound-based radiomics and inflammation-related markers.

Yu-Ting Peng, Jin-Shu Pang, Peng Lin, Jia-Min Chen, Rong Wen, Chang-Wen Liu, Zhi-Yuan Wen, Yu-Quan Wu, Jin-Bo Peng, Lu Zhang and 3 more

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yu-Ting Peng *Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Jin-Shu Pang *Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Peng LinDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, No.29 Xinquan road, Fuzhou, Fujian Province, China.
Jia-Min ChenDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Rong WenDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Chang-Wen LiuDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Zhi-Yuan WenDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Yu-Quan WuDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Jin-Bo PengDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Lu ZhangDepartment of Medical Pathology, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Hong YangDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China.
Dong-Yue WenDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China. 844653793@qq.com.
Yun HeDepartment of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, No.6 Shuangyong, Road, Nanning, Guangxi Zhuang Autonomous Region, China. heyun@stu.gxmu.edu.cn.

Funding

the National Natural Science Foundation of China No. 82160336
6 · The paper itself

Abstract

objectivesTo develop ultrasound-based radiomics models and a clinical model associated with inflammatory markers for predicting intrahepatic cholangiocarcinoma (ICC) lymph node (LN) metastasis. Both are integrated for enhanced preoperative prediction.

methodsThis study retrospectively enrolled 156 surgically diagnosed ICC patients. A region of interest (ROI) was manually identified on the ultrasound image of the tumor to extract radiomics features. In the training cohort, we performed a Wilcoxon test to screen for differentially expressed features, and then we used 12 machine learning algorithms to develop 107 models within the cross-validation framework and determine the optimal radiomics model through receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression analysis was used to identify independent risk factors to construct a clinical model. The combined model was established by combining ultrasound-based radiomics and clinical parameters. The Delong test and decision curve analysis (DCA) were used to compare the diagnostic efficacy and clinical utility of different models.

resultsA total of 1239 radiomics features were extracted from the ROIs of tumors. Among the 107 prediction models, the model (Stepglm + LASSO) utilizing 10 radiomics features ultimately yielded the highest average area under the receiver operating characteristic curve (AUC) of 0.872, with an AUC of 0.916 in the training cohort and 0.827 in the validation cohort. The combined model, which incorporates the optimal radiomics score, clinical N stage, and platelet-to-lymphocyte ratio (PLR), achieved an AUC of 0.882 in the validation cohort, significantly outperforming the clinical model with an AUC of 0.687 (P = 0.009). According to the DCA analysis, the combined model also showed better clinical benefits.

conclusionsThe combined model incorporating ultrasound-based radiomics features and the PLR marker offers an effective, noninvasive intelligence-assisted tool for preoperative LN metastasis prediction in ICC patients. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaLymphatic MetastasisUltrasonographyAgedBiomarkers, TumorFemaleHumansInflammationMachine LearningMaleMiddle AgedRadiomicsRetrospective StudiesROC CurveBiomarkers, TumorInflammation-related markerIntrahepatic cholangiocarcinomaLymph node metastasisRadiomicsUltrasound

Identifiers

PMID39748308
PMCPMC11697736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.